John Todd | |
---|---|
Born | John Andrew Todd 23 June 1958 |
Citizenship | United Kingdom |
Alma mater | University of Edinburgh |
Awards | David Rumbough Award for Scientific Excellence |
Scientific career | |
Fields | Human Genetics |
Institutions | University of Cambridge Stanford University University of Oxford Wellcome Trust |
Doctoral advisor | Professor David Ellar |
Website | https://www.well.ox.ac.uk/people/john-todd |
John Andrew Todd FMedSci FRS (born 23 June 1958) is Professor of Precision Medicine at the University of Oxford, [1] director of the Wellcome Center for Human Genetics [2] and the JDRF/Wellcome Trust Diabetes and Inflammation Laboratory, [3] in addition to Jeffrey Cheah Fellow in Medicine at Brasenose College. [4] He works in collaboration with David Clayton and Linda Wicker to examine the molecular basis of type 1 diabetes. [5] [6]
Todd was born on 23 June 1958. [7] He received a Bachelor of Science (BSc) degree in biological sciences from the University of Edinburgh in 1980. He went on to study biochemistry at the University of Cambridge, where he was supervised by David Ellar, completing his Doctor of Philosophy (PhD) degree in 1983 with a thesis entitled "Penicillin-binding proteins during growth and differentiation of bacilli". [8]
Dame Kay Elizabeth Davies is a British geneticist. She is Dr Lee's Professor of Anatomy at the University of Oxford and a Fellow of Hertford College, Oxford. She is director of the Medical Research Council (MRC) functional genetics unit, a governor of the Wellcome Trust, a director of the Oxford Centre for Gene Function, and a patron and Senior Member of Oxford University Scientific Society. Her research group has an international reputation for work on Duchenne muscular dystrophy (DMD). In the 1980s, she developed a test which allowed for the screening of foetuses whose mothers have a high risk of carrying DMD.
Dame Frances Mary Ashcroft is a British ion channel physiologist. She is Royal Society GlaxoSmithKline Research Professor at the University Laboratory of Physiology at the University of Oxford. She is a fellow of Trinity College, Oxford, and is a director of the Oxford Centre for Gene Function. Her research group has an international reputation for work on insulin secretion, type II diabetes and neonatal diabetes. Her work with Andrew Hattersley has helped enable children born with diabetes to switch from insulin injections to tablet therapy.
Veronica van Heyningen is an English geneticist who specialises in the etiology of anophthalmia as an honorary professor at University College London (UCL). She previously served as head of medical genetics at the MRC Human Genetics Unit in Edinburgh and the president of The Genetics Society. In 2014 she became president of the Galton Institute. As of 2019 she chairs the diversity committee of the Royal Society, previously chaired by Uta Frith.
Gilean Alistair Tristram McVean is a professor of statistical genetics at the University of Oxford, fellow of Linacre College, Oxford and co-founder and director of Genomics plc. He also co-chaired the 1000 Genomes Project analysis group.
The JDRF/Wellcome Trust Diabetes and Inflammation Laboratory , centred in the Cambridge Institute for Medical Research, is a multi-disciplinary research programme within the department of Medical Genetics at the University of Cambridge. The current director is John Todd FMedSci FRS and Professor of Medical Genetics at the University of Cambridge.
Martin Bobrow is a British geneticist, and Emeritus Fellow, Wolfson College, Cambridge.
Simon Tavaré is the founding Director of the Herbert and Florence Irving Institute of Cancer Dynamics at Columbia University. Prior to joining Columbia, he was Director of the Cancer Research UK Cambridge Institute, Professor of Cancer Research at the Department of Oncology and Professor in the Department of Applied Mathematics and Theoretical Physics (DAMTP) at the University of Cambridge.
Rajesh Vasantlal Thakker is May Professor of Medicine in the Nuffield Department of Clinical Medicine at the University of Oxford and a fellow of Somerville College, Oxford. Thakker is also a Consultant physician at the Churchill Hospital and the John Radcliffe Hospital, Principal investigator (PI) at the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) and was Chairman of the NIHR/MRC Efficacy and Mechanism Evaluation (EME) Board until Spring 2016.
Edward Thomas Bullmore, is a British neuropsychiatrist, neuroscientist and academic. Since 1999, he has been Professor of Psychiatry at the University of Cambridge and since 2014, Head of the Department of Psychiatry. In 2005, he also became Vice-President of Experimental Medicine at GlaxoSmithKline while maintaining his post at University of Cambridge.
(Edith) Yvonne JonesFLSW is director of the Cancer Research UK Receptor Structure Research Group at the University of Oxford and a Fellow of Jesus College, Oxford. She is widely known for her research on the molecular biology of cell surface receptors and signalling complexes.
Vengalil Krishna Kumar Chatterjee is a British endocrinologist. He is a professor of endocrinology in the Department of Medicine at the University of Cambridge and a fellow of Churchill College, Cambridge. He is also the director of the Cambridge Clinical Research Centre, part of the National Institute for Health Research (NIHR).
Sharon Jayne Peacock is a British microbiologist who is Professor of Public Health and Microbiology in the Department of Medicine at the University of Cambridge.
Andrew John King is a Professor of Neurophysiology and Wellcome Trust Principal Research Fellow in the Department of Physiology, Anatomy and Genetics at the University of Oxford and a Fellow of Merton College, Oxford.
Dominic Kwiatkowski was an English medical researcher and geneticist who was head of the parasites and microbes programme at the Wellcome Sanger Institute in Cambridge and a Professor of Genomics at the University of Oxford. Kwiatkowski applied genomics and computational analysis to problems in infectious disease, with the aim of finding ways to reduce the burden of disease in the developing world.
Nicole Soranzo is an Italian-British senior group leader in human genetics at the Wellcome Sanger Institute, Professor of Human Genetics at the University of Cambridge. She is an internationally recognised Human Geneticist who has focused on the application of cutting edge genomic technologies to study the spectrum of human genetic variation associated with cardio-metabolic and immune diseases. She has led many large-scale discovery efforts including more than 1,000 novel genetic variants associated with cardio-metabolic diseases and their risk factors as well as establishing the HaemGen consortium, which is a worldwide effort to discover genetic determinants of blood cell formation and also interpretation of the downstream consequences of sequence variation through a host of integrative analyses and functional approaches.
The Department of Genetics is a department of the University of Cambridge that conducts research and teaching in genetics.
Irene Mary Carmel Tracey is Vice-Chancellor of the University of Oxford and former Warden of Merton College, Oxford. She is also Professor of Anaesthetic Neuroscience in the Nuffield Department of Clinical Neurosciences and formerly Pro-Vice-Chancellor at the University of Oxford. She is a co-founder of the Oxford Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB), now the Wellcome Centre for Integrative Neuroimaging. Her team’s research is focused on the neuroscience of pain, specifically pain perception and analgesia as well as how anaesthetics produce altered states of consciousness. Her team uses multidisciplinary approaches including neuroimaging.
Professor Patrick Francis Chinnery, FRCP, FRCPath, FMedSci, is a neurologist, clinician scientist, and Wellcome Trust Principal Research Fellow based in the Medical Research Council Mitochondrial Biology Unit and the University of Cambridge, where he is also Professor of Neurology and Head of the Department of Clinical Neurosciences.
Melanie Jane Davies, is a British physician and academic, who specialises in type 2 diabetes mellitus. Since 2007, she has been Professor of Diabetes Medicine at the University of Leicester. She is the director of the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre.
Irene Miguel-Aliaga is a Spanish-British physiologist who is Professor of Genetics and Physiology at Imperial College London. Her research investigates the plasticity of adult organs, and why certain organs change shape in response to environmental changes. She was elected Fellow of the Royal Society in 2022.
{{cite web}}
: Missing or empty |url=
(help)